Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Promising heterocycle-based scaffolds in recent (2019–2021) anti-Alzheimer's drug design and discovery
Atukuri Dorababu
European Journal of Pharmacology (2022) Vol. 920, pp. 174847-174847
Closed Access | Times Cited: 21

Showing 21 citing articles:

[3 + 2] Cycloaddition Synthesis of New (Chromene‐1,3,4‐Oxadiazole) Hybrids Linked to Pyrazole Units as Potential Acetylcholinesterase Inhibitors
A.A. Ahmed, Ahmed E. M. Mekky, Sherif M. H. Sanad
ChemistrySelect (2025) Vol. 10, Iss. 2
Closed Access | Times Cited: 1
Synthesis of new fluorinated sulfonates and their Schiff bases as anti-Alzheimer drug candidates: An in vitro-in silico study
Reşit Çakmak, Eyüp Başaran, Selami Ercan, et al.
Journal of Molecular Structure (2025), pp. 141474-141474
Closed Access | Times Cited: 1
Exploring Fluorine-Substituted Piperidines as Potential Therapeutics for Diabetes Mellitus and Alzheimer’s Diseases
Ehsan Ullah Mughal, Mohammed B. Hawsawi, Nafeesa Naeem, et al.
European Journal of Medicinal Chemistry (2024) Vol. 273, pp. 116523-116523
Closed Access | Times Cited: 9
Innovative approaches to Alzheimer's therapy: Harnessing the power of heterocycles, oxidative stress management, and nanomaterial drug delivery system
Mohammad Umar, Yasir Rehman, Subiya Ambreen, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102298-102298
Closed Access | Times Cited: 7
Recent advancements in the synthesis of fused thienopyridines and their therapeutic applications
Ranjay Shaw, Ritu Tewari, Monika Yadav, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 12, pp. 100185-100185
Open Access | Times Cited: 5
Development of multifunctional fluorescence-emitting potential theranostic agents for Alzheimer’s disease
Nilesh Gajanan Bajad, Gajendra T.A., Mansi Kothari, et al.
Talanta (2025) Vol. 287, pp. 127574-127574
Closed Access
The literature of heterocyclic chemistry, part XXII, 2022
Галина А. Газиева, Yu. B. Evdokimenkova, N. O. Soboleva
Advances in heterocyclic chemistry (2025)
Closed Access
BACE-1 Inhibitors Targeting Alzheimer's Disease
Kadja Luana Chagas Monteiro, Marcone Gomes dos Santos Alcântara, Nathalia Monteiro Lins Freire, et al.
Current Alzheimer Research (2023) Vol. 20, Iss. 3, pp. 131-148
Closed Access | Times Cited: 11
[3+2] Cycloaddition Synthesis of New Piperazine‐Linked Bis(chromene) Hybrids Possessing Pyrazole Units as Potential Acetylcholinesterase Inhibitors
Ahmed E. M. Mekky, Sherif M. H. Sanad
Chemistry & Biodiversity (2023) Vol. 20, Iss. 4
Closed Access | Times Cited: 9
Design, synthesis, and evaluation of hydrazones as dual inhibitors of ryanodine receptors and acetylcholinesterases for Alzheimer’s disease
Fan Yang, Jiangang Zhao, Guang Chen, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106432-106432
Closed Access | Times Cited: 7
1,2,3-Triazolo[4,5-b]aminoquinolines: Design, synthesis, structure, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activity, and molecular docking of novel modified tacrines
Yuri G. Kappenberg, Pablo A. Nogara, Felipe S. Stefanello, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106704-106704
Closed Access | Times Cited: 6
Access to 8-Aminoindolizine Fused with Quinone via Cu(OAc)2-Catalyzed Domino [4+2] Annulation
Sun Hee Lee, Yechan Lee, W. Namkung, et al.
Synthesis (2024) Vol. 56, Iss. 11, pp. 1799-1806
Closed Access | Times Cited: 1
Some Heterocycles Connected to Substituted Piperazine by 1,3,4-Oxadiazole Linker: Design, Synthesis, Anticholinesterase and Antioxidant Activity
Zühal Kılıç-Kurt, Dilan Konyar, Hayati OKUR, et al.
Journal of Molecular Structure (2024) Vol. 1321, pp. 139854-139854
Closed Access | Times Cited: 1
[3 + 2] Cycloaddition synthesis of new (nicotinonitrile-chromene) hybrids linked to pyrazole units as potential acetylcholinesterase inhibitors
Sherif M. H. Sanad, Ahmed E. M. Mekky
Synthetic Communications (2022) Vol. 52, Iss. 16, pp. 1672-1684
Closed Access | Times Cited: 8
[3+2] cycloaddition synthesis of new (nicotinonitrile‐chromene)‐based bis(pyrazole) hybrids as potential acetylcholinesterase inhibitors
Ahmed E. M. Mekky, Sherif M. H. Sanad
Journal of Heterocyclic Chemistry (2022) Vol. 60, Iss. 1, pp. 156-160
Closed Access | Times Cited: 7
Ultrasound‐Mediated Synthesis of New (Piperazine‐Chromene)‐Linked Bis(thieno[2,3‐b]pyridine) Hybrids as Potential Anti‐acetylcholinesterase
Sherif M. H. Sanad, Ahmed E. M. Mekky
ChemistrySelect (2022) Vol. 7, Iss. 41
Closed Access | Times Cited: 7
Prediction by DFT and Synthesis of new Xanthene Derivatives: Evaluation of their Toxicity and Antihyperlipidemic Properties In-Vivo and In-Silico
Mohammed El Mesky, Hicham Zgueni, Yassine Rhazi, et al.
Journal of Molecular Structure (2024) Vol. 1313, pp. 138705-138705
Closed Access
Synthesis and Neurobehavioral Evaluation of a Potent Multitargeted Inhibitor for the Treatment of Alzheimer’s Disease
Mohd Shahnawaz Khan, Zuber Khan, Nasimudeen R. Jabir, et al.
Molecular Neurobiology (2024)
Closed Access
Design, Creation, and Biological Screening of Newer Coumarin-Coupled Heterocyclic Hybrids as Acetylcholinesterase Inhibitors that may be Useful in the Treatment of Alzheimer’s Disease
Sati Bhawana, Tyagi Alka, Anurag Anurag
Pharmaceutical Chemistry Journal (2024) Vol. 58, Iss. 7, pp. 1069-1083
Closed Access
Recent advancements in the therapeutic approaches for Alzheimer's disease treatment: Current and future perspective
Amit Sharma, Santosh Rudrawar, Sandip B. Bharate, et al.
RSC Medicinal Chemistry (2024)
Open Access
Synthesis and Potential Dual Inhibitory Activity Against Acetylcholinesterase and Butyrylcholinesterase of Galactose‐Conjugated Isatin β‐Thiosemicarbazones
Nguyễn Đình Thành, Nguyễn Thị Kim Giang, Vũ Ngọc Toán, et al.
ChemistrySelect (2023) Vol. 8, Iss. 22
Closed Access | Times Cited: 1
Page 1

Scroll to top